https://www.optimumcomms.com/wp-content/uploads/2023/02/Verona_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-02 16:19:372023-06-09 15:20:14Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023
https://www.optimumcomms.com/wp-content/uploads/2023/02/Verona_Logo_300-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-02 16:19:372023-06-09 15:20:14Verona Pharma to Present Expanded Analyses of Positive Phase 3 ENHANCE Studies in COPD in Multiple Presentations at ATS 2023
https://www.optimumcomms.com/wp-content/uploads/2023/02/Sequana_Medical_Logo_300x180px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-02 10:05:182023-06-15 11:12:11Sequana Medical announces FDA clearance of IND application for DSR® 2.0 for treatment of congestive heart failure
https://www.optimumcomms.com/wp-content/uploads/2023/06/Destiny_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-02 08:54:112023-06-15 11:15:18Destiny Pharma and SporeGen® announce update from research collaboration under Innovate UK grant award to develop a biotherapeutic treatment (SPOR-COV®) for COVID-19 and Influenza
https://www.optimumcomms.com/wp-content/uploads/2023/02/CurveTx_Logo_300x180px-80x80-Recovered.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-05-02 08:39:102023-06-15 11:17:41Curve Therapeutics Expands Leadership Team and Scientific Advisory Board
https://www.optimumcomms.com/wp-content/uploads/2023/02/Neuraxpharm_Logo_300px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-27 17:29:162023-06-15 11:18:28Neuraxpharm agrees on the divestment of inhalation API specialist Inke to Keensight Capital
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-27 08:34:402023-06-15 11:20:07ISA Pharmaceuticals to Present Pre-clinical Data on its Protective SLP Therapy Against SARS-CoV-2 at the CIMT Annual Meeting
https://www.optimumcomms.com/wp-content/uploads/2023/06/Aldena_Logo_300x180px-80x80-6.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-26 08:38:412023-06-15 11:20:29Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
https://www.optimumcomms.com/wp-content/uploads/2023/06/NovoFund_Logo_300x180px-80x80-1.png
180
300
LRuas
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
LRuas2023-04-25 10:10:342023-06-15 11:20:59Massive investment in fundamental cardiometabolic research addresses a growing global public health crisis
https://www.optimumcomms.com/wp-content/uploads/2023/02/Alchemab_Logo_300px-2.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-25 10:03:192023-06-15 11:25:23Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-20 08:46:202023-06-15 11:24:30ISA Pharmaceuticals to Attend and Present at Upcoming Scientific and Business Conferences in May and June of 2023
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-20 08:43:272023-06-15 11:23:00Breye Therapeutics Strengthens Management Team and Board
https://www.optimumcomms.com/wp-content/uploads/2023/05/Engimmune_Logo_300x180px-80x80-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-19 10:54:562023-06-15 11:22:41Engimmune Therapeutics appoints Dr. Lars Nieba as Chief Executive Officer
https://www.optimumcomms.com/wp-content/uploads/2023/02/Bioinnovation-_Logo_300x180px-1.png
180
300
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-18 12:05:262023-06-15 11:22:24Ferring and BioInnovation Institute enter new strategic collaboration to accelerate innovation in women’s health
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-18 09:19:412023-04-18 09:19:41NeoPhore signs research collaboration with The Institute of Cancer Research, London
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-18 08:14:482023-04-18 08:14:48Ariceum Therapeutics Announces Extension of Series A Financing to EUR 47.75M to Advance its Next Generation Radiopharmaceutical Clinical Pipeline
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
0
0
Healthcare Team
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
Healthcare Team2023-04-18 07:57:482023-04-18 07:57:48Futura Medical Announces MED3000, Eroxon® UK LaunchWe’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
